Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients
Rosalie Lubbers(Charles River Laboratories (Netherlands)), Leendert A. Trouw(Leiden University Medical Center), Tom H. M. Ottenhoff(Office of Infectious Diseases), Simone A. Joosten(Leiden University Medical Center), Douwe J. Dijkstra(Leiden University Medical Center), Gerhard Walzl(South African Medical Research Council), Marcel Veltkamp(University Medical Center Utrecht), Willem Jan W. Bos(St. Antonius Ziekenhuis), Stefan M.T. Vestjens(St. Antonius Ziekenhuis), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Jayne S. Sutherland(MRC Unit the Gambia), Geert H. Groeneveld(Leiden University Medical Center), Kyra A. Gelderman(Sanquin), Linda Petrone(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Roelof A. de Paus(Leiden University Medical Center), Stephanus T. Malherbe(South African Medical Research Council), Coline H.M. van Moorsel(Inserm), Annemieke Geluk(Leiden University)
Cited by 33
Related Papers
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
|Human Immunology|2004|413
Diagnosis of Childhood Tuberculosis and Host RNA Expression in Africa
|New England Journal of Medicine|2014|392